chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Developed bell's palsy on the left side of my face; My mouth and side of my face started to feel numb within a half hour of receiving the vaccine; My mouth and side of my face started to feel numb within a half hour of receiving the vaccine; Within 24 hours the entire side of my face from my jaw to my eye was numb; This is a spontaneous report from a contactable consumer (patient, self-reported). A 54-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EN0164 and expiry date was not provided), via an unspecified route of administration, in Arm Left, on 15Apr2021 at 10:00 AM, as a single dose for COVID-19 immunization. The patient was not pregnant at the time of vaccination. The patient's medical history included bee venom (known allergies). Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccination. The patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient reported that on 15Apr2021 at 10:30 AM, she developed bell's palsy on the left side of her face. Her mouth and side of her face started to feel numb within a half hour of receiving the vaccine. Within 24 hours the entire side of her face from her jaw to her eye was numb. The patient received Medrol 4 mg dosepak and Valtrex - 7-day dose as treatment for the events. The events resulted in physician office visit. Outcome of the events was not recovered.  Information on Lot/Batch number was available. Additional information has been requested.
This spontaneous report as received from a registered nurse referring to her 11 year old son with prune belly at birth, intestinal function problems, hydronephrosis, polycystic kidney, baby size right kidney and unspecified musculoskeletal conditions. On 21-SEP-2015, the patient was vaccinated with a dose of GARDASIL 9 (dose, Lot #, expiration date and route were not provided) one shot in the arm. Concomitant therapies included COLACE. On 24-SEP-2015, the patient experienced an allergic reaction that included a large lump in his arm, redness, rash, swelling in the top of the shoulder area, fever of 102.6, he could not feel his fingers, could not lift his arm, and felt tired, he had red bumps in the back of his throat and swelling in his throat and a weird cough. On the same date, the patient sought medical attention but was not admitted. So the patient's mother treat the patient with ice and heat off on the arm, TYLENOL and ibuprofen "but it did not work". On 01-OCT-2015, also reported as today, the patient sought medical attention again, at an unspecified location. A quick test strip was taken for Streptococcal throat and the result was negative. There was not a product quality complain involved. At the time of this report, the outcome of the allergic reaction was reported as not recovered. The relatedness between the events and suspect therapy was not provided. Additional information has been requested.
3JAN97 T102.4 x 2 days;APAP alternated w/motrin q 4hr x 3 days;3JAN97 rash red started on trunk & spread to head & toes by 4JAN98;8JAN97 rash turned brown;7JAN97 MD reported measles like rash, congestion, enlarged spleen,spots in mouth;
contracted COVID after the first dose; contracted COVID after the first dose; This is a spontaneous report from a contactable nurse (patient).  A 36-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 22Dec2020 at a single dose for COVID-19 vaccine. Medical history and concomitant medications were not reported. It was reported that the patient contracted COVID after the first dose on an unspecified date. He has question about the second dose. He had his first dose on 22Dec2020. He contracted COVID in-between doses. His second dose was due today. He wanted to know if he should receive it today or what was the safety issue. He asked if was it safe to get the second dose of his COVID vaccine if he had COVID? Lab data included COVID-19 positive on an unspecified date. The outcome of 'contracted COVID after the first dose' was unknown.   Information on the lot/ batch number has been requested.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. However, full immunity is only expected 2 weeks after the second dose.
Pt recvd 2 doses of Engerix-B & 12AUG92 devel syncope, weakness on lt side from head to foot; pt was not sure where was @ times; stupor; pt seen in ER; MD indicated pt had stroke-like sx;
It's been over a  month since my injection and I still have severe pain at the injection site & upwards towards my shoulder. I have limited range of motion and lifting above 45° angle is very painful. Pain has been increasing in recent days. During my vaccine I had a very strong burning sensation within my arm that I've never experienced with any other shot. My bruising lasted for 2+ weeks.
HEADACHE AFTER THE BOOSTER SHOT TILL TODAY WHICH IS ALREADY 3 DAYS AFTER THE SHOT. HAVE HIVES AFTER TWO DAYS GETTING THE BOOSTER
received 0.6 mL of Shingrix instead of 0.5 mL; This case was reported by a pharmacist via call center representative and described the occurrence of overdose in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix .6 ml. On an unknown date, unknown after receiving Shingrix, the patient experienced overdose. On an unknown date, the outcome of the overdose was unknown.  Additional details were reported as follows: The patient received 0.6 mL of Shingrix instead of 0.5 mL, which led to overdose. No more information available since reporter was not at work. Due to communication issues, a lot of information was not requested or tried to be confirmed after reporter mentioned the limited data available due to them not being at work. The reporter consented to follow up. This case has been linked with case ID US2021151034, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021151034:Same reporter
admit with CHF, weakness, SOB x 1 week, sats 75% on RA. placed on bipap in ER O2 at 25L, sats up to 92%.  BG was 417. DX: Pneumonia, sepsis, COVID +, DKA, NSTEMI; avoid remdisivir an toci. start dexamethasone.  sepsis and AKI. Insulin drip for DKA.  O2 @ 10 L Oxymask. Renal function worsening, pt does not want HD - states would not want more than 1-2 HD treatments. met with palliative care.  pt not making urine. 11/21 becomes more confused, needs sitter.  11/22 more confused, combative and uncooperative. family and physician discussion options of HD vs hospice. pt becoming more lethargic.   placed on hospcie
worn out/stayed in bed most of the day; Anxiety; Arm hurt for 3 days; Vomiting; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 07-Apr-2021. The most recent information was received on 28-Apr-2021 and was forwarded to Moderna on 28-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxiety), PAIN IN EXTREMITY (Arm hurt for 3 days), VOMITING (Vomiting) and FATIGUE (worn out/stayed in bed most of the day) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy, Food allergy (Egg white, Wheat, Turkey), Anxiety since December 1987, Pain and Allergy (allergies outside). Concomitant products included MARIJUANA for Anxiety and Pain.    On 07-Apr-2021 at 4:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced ANXIETY (Anxiety), PAIN IN EXTREMITY (Arm hurt for 3 days) and VOMITING (Vomiting). On 08-Apr-2021, the patient experienced FATIGUE (worn out/stayed in bed most of the day). On 07-Apr-2021, VOMITING (Vomiting) had resolved. On 09-Apr-2021, PAIN IN EXTREMITY (Arm hurt for 3 days) had resolved. At the time of the report, ANXIETY (Anxiety) and FATIGUE (worn out/stayed in bed most of the day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient took Ostillococcinum for allergy before vaccination. Treatment information was not provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Initiative: communication regarding sending of form, believe she may have sent it, needs phone number. On 28-Apr-2021: Significant follow-up: New events added, medical history updated.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Papular rash on bridge of nose and around upper lip. Entire chin is red in circular pattern. No swelling of lips, no symptoms related to mouth or airway. No swelling of tongue or throat.
Fever of 99.3 degrees that lasted approximately 4 hrs at one day post injection (10/27/2018). During the day the left tonsil and lymph nodes were swollen and painful. Swelling and pain were present until November 1st. During that time yellow and green mucus and phlegm were coming from nose and throat and I was feeling tired. The right side of my throat was not having any issues only the left one.
soreness at inj site 5/10; joint pain, mild; low appetite; mild headache; malaise; This is a spontaneous report from a contactable consumer (patient, self-reported). A 30-year-old patient of an unspecified gender received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on 30Jan2021, as a single dose for COVID-19 immunization. The patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on 09Jan2021, as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that on an unknown date, about 17 hours post injection, the patient had soreness at inj site 5/10, joint pain, mild, low appetite, mild headache, and malaise. The patient was not reported about nausea, vomiting, rash, fever, diarrhea or any other s/s. Duration of events was 24/30 hours. The patient took treatment as 400mg Advil 2x, most above s/s resolved, Inc fluid intake, and rest. Outcome of the events was resolved on an unknown date.  Information on the lot/batch number has been requested.  Follow-up attempts have been completed and no further information is expected.
Patient initially developed arm soreness, then thirst, then hypotension beginning the AM after injection. Hypotension was accompanied by lightheadedness. BP checked at home with home monitor while sitting was 85/53, then 72/33. Patient became more lightheaded. Husband was advised to call 911. She is currently in ER undergoing treatment.
30 minutes after injection started having itching.  Dr.  assessed and ordered patient to take own Zyrtec. 30 minutes after taking zyrtec, itching gone.
This report is regarding the Pfizer COVID-19 vaccination you received on the above date, which was lot  number FD0809. The Public Health District, per guidance from the Department of  Health, Centers for Disease Control and Prevention (CDC), and Pfizer have determined that the  dose of vaccine that you received is valid.
Nothing until about May when the AFib became more prevalent resulting in Cardio Inversion in June. AFib condition reappeared in October that after attempt to control with medication, December 28, 2021, ablation was preformed. Booster given 9/29/2021.
1st 24 hours: alternating uncontrollable shivering and hot sweats, fever of 100+, severe fatigue, intense headache and eyeache, painful prickling sensation throughout the skin, inability to wake (slept 22 out of 24 hours), dreams replaced with nonsense word repetition without visuals, brain fog next 6 days: continued fatigue and brain fog (felt like being drunk or high for the first half, then lightened to being dizzy), recurrence of oral herpes that was not suppressible by valacyclovir, vertigo, occasional prickling sensation on skin, weakness in hands and legs, difficulty climbing stairs, moderate to severe headache.
mild fever (high of 100.7), body aches  fever from 2:30am to 8:30am when I took medication for pain that was also a fever reducer pain subsided, along with fever
pt states that the day after she took the vax her right arm was red and had a small sore spot around the injection site.  On 2/27/21 she started itching from her waist to the top of the head. She took Benadryl every 4 hours to help w/ these symptoms that lasted about 4 days.  On day 11,  her right arm became red again and she had a spot about the size of a silver dollar around the injection site that lasted a couple of days.  Pt says all of these symptoms have subsided.
14th day post immunizations developed red raised rash over entire body except palsm/soles. No vesivles/pustules present. Fever of 103 F. Approximately 100 spots/mother. Took child to EMR, physician attributed rash/fever to immu perscribed steroid cream and NASAIDS's. Day 3-4 resolved all symptoms.
pt was taken to ER 27SEP92 p/woke up w/red raised rash all over body; c/o itching & feet were swollen; pt was given DPH; had fever;
Sore arm; fatigue; This is a spontaneous report from a contactable other healthcare professional, the patient. A 53-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EN6207) via unspecified route of administration in the left arm on 21Mar2021 at 14:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included depression/anxiety, psoriasis. No known allergies were reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had not received any other vaccines within 4 weeks prior to the vaccine. Medications received in two weeks included vitamins (MANUFACTURER UNKNOWN), TRINTELLIX, trazadone (MANUFACTURER UNKNOWN), melatonin (MANUFACTURER UNKNOWN) all for unknown indications and from unknown dates. Since the vaccination, the patient had not been tested for COVID-19. On 21Mar2021 at 20:45, patient experienced sore arm, fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the events sore arm, fatigue. The clinical outcome of the events sore arm, fatigue were not recovered.   No follow-up attempts are needed. No further information is expected.
This spontaneous report was received from a registered nurse and refers to a 12 month old male patient. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 14-OCT-2016, the patient was vaccinated with an improperly stored PROQUAD lot # M022402 with expiration date of 01-NOV-2017 (dose, route and frequency were not reported) for prophylaxis. It was stated that the vaccine underwent a temperature excursion of 6 degrees Fahrenheit to 14 degrees Fahrenheit for 17 days. It was reported that there was no need to repeat vaccine. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1705USA013888.
Patient was given 2nd dose past expiration; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was given 2nd dose past expiration) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was given 2nd dose past expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was given 2nd dose past expiration) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment information was unknown.
Within a day of receiving the first dose, I had fever, chills, leg pains that resolved within 24 hours.  However within two weeks, I started experiencing stomach issues and multiple bowel movements per day.  Then on 9/14/21 I was admitted to Medical for a seven day stay for moderate sigmoid diverticulitis with perforations.
Patient stated that 3 days later he came down with hives and a swollen face and lip.
Rash on my arm & soreness of where The shot was given & also had migraine headaches
This spontaneous report as received from a pharmacist refers to a patient of unknown age or gender. The pharmacist was informed by an unspecified pharmacist that an unspecified patient was vaccinated with ZOSTAVAX in 2012 and received a second dose of ZOSTAVAX in DEC-2014. No adverse effects were reported. No patient identifying information was available. No further information was provided. Additional information is not expected.
approx 4hr p/vax pt was in bouncer seat & had 2 1min episodes about 15mins apart in which pt arched, eye rolled back & had rhythmic jerking of extremities;afterwards seemed out of it but w/o 5 mins was back to nl
Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 57-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 22-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was not provided. It was reported that vaccines were stored in freezer and they took out one to two vials and placed in fridge each day as needed.
Pt experience very high fever, shivering - thought he was going to have seizure. Took 2 acetaminophen 500mg - symptoms resolved.
shortness of breath; Cough; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), COUGH (Cough) and FATIGUE (fatigue) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced DYSPNOEA (shortness of breath), COUGH (Cough) and FATIGUE (fatigue). At the time of the report, DYSPNOEA (shortness of breath) and COUGH (Cough) outcome was unknown and FATIGUE (fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information provided. No treatment information provided.
SORE ARM, NECK ACHE, SWELLING IN FEET & ANKLES, HIGH BLOOD PRESSURE, HAD TO GO TO ER BECAUSE OF HIGH BLOOD PRESSURE, DR EVERY 2 WEEKS, BLOOD WORK, CALCIUM TEST, ECHO TEST, KIDNEY TEST, EKG, HEAD SCAN, TO CARXIOLOGIST FOR HEART TEST.
52 year old female with past medical history of hypertension, DM type 2, pituitary adenoma, presented to ED for nausea, vomiting, fever, cough and unable to tolerate anything PO. Symptom onset was 9/24, she works as a nurse, got tested for COVID Friday 9/24, rapid test was negative, retested Monday 9/27 due to worsening symptoms which resulted positive. Nausea and vomiting persisted and patient become short of breath which prompted her visit to the ED on 9/29. Patient required 3 L of oxygen and was given IV Phenergan for her nausea which helped. She was also started on Remdesivir on 9/30 and Dexamethasone on 9/29. She was started on Lantus and Lispro for BG control. Her hospital course was marked by increasing oxygen requirements which prompted a D-dimer, which was negative for suspicion of DVT/PE. Pt had worsening oxygen requirement of up to 7L, and a D-dimer that doubled, so CT-PE ordered on 10/03 and was negative for PE. Patient continued to improve clinically with lessening cough and oxygen requirement. A walking home O2 evaluation showed that she needed 3 L to maintain on O2 saturation of 88% while ambulating. Patient completed both her Remdesivir and Dexamethasone course while inpatient.  Admitted 10/1/21 and discharged 10/8/21
On Saturday, September 25, 2021 client came to vaccination POD for a Covid-19 Janssen dose. Client stated to ancillary staff during check-in process that he was vaccinated with Covid-19 vaccine 7 months ago in February, without proof of vaccination. At this time Covid-19 vaccine is not a vaccine approved. Elevated to Medical team & Vaccine Operations Lead and approved client to get the Janssen vaccine as it has been more than 28 days since receiving the one dose of non-FDA-authorized Covid-19 vaccine. Client has no history of allergies or previous adverse reactions to other vaccines. Client was to be a 15 minute wait in the Observation Area. Client received his Covid-19 Janssen (LOT #: 211A21A) at approximately 10:32 AM in his left arm. Client experienced no adverse reaction while waiting in Observation Area and left vaccination site with a steady gait at approximately 10:50 AM.
I expected soreness at injection site on Mon.  But next day (Tues) i  felt feverish and went home early from work. The next day (Wednesday) the feverish feeling was gone but my upper cheeks hurt and felt a little swollen.    The next day (Thurs), cheeks still a little tender and fluid sacks under eyes.  Friday about same, and all the while have felt very tired.
Myalgia, Fever, SkinRash, Chills, Fatigue, Redness at injection site size of egg Narrative:
Information has been received on a TV show from a reporter concerning the little daughter of a lady who on an unknown date, was vaccinated with a dose of GARDASIL (route, dose and lot number not reported). On an unknown date, the mother told to the reporter that her little daughter took the vaccine injection and she suffered from mental retardation thereafter. It was unknown if the patient sought medical attention. At the time of the report the outcome of the patient was unknown. This is one of several reports received from the same source. Upon internal review, mental retardation was determined to be an other important medical event. No further information is available.